Blue Trust’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Blue Trust's RMD Position: Q3 2026 in Review
Blue Trust reduced its ResMed (RMD) stake by 75% in Q3 2026, selling an estimated $46.2K and leaving 70 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1585.
Blue Trust first reported a position in RMD in Q2 2022 and has held it in 18 quarters since. The position peaked at $186K in Q3 2024. 789 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Blue Trust held 70 shares of ResMed worth $15.5K as of Q3 2026.
- Blue Trust sold 212 ResMed shares in Q3 2026, an estimated $46.2K.
- ResMed made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1585 holding.
- Blue Trust first reported a position in ResMed in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's ResMed position peaked at $186K in Q3 2024.
- 789 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.